Home/Filings/4/A/0001144204-19-041520
4/A//SEC Filing

MERIDIAN VENTURE PARTNERS II LP 4/A

Accession 0001144204-19-041520

CIK 0001023024other

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 2:13 PM ET

Size

12.9 KB

Accession

0001144204-19-041520

Insider Transaction Report

Form 4/AAmended
Period: 2019-08-19
Transactions
  • Sale

    Common Stock

    2019-08-19$68.30/sh2,067$141,1762,286,795 total
  • Sale

    Common Stock

    2019-08-20$68.18/sh5,512$375,8082,281,283 total
Transactions
  • Sale

    Common Stock

    2019-08-19$68.30/sh2,067$141,1762,286,795 total
  • Sale

    Common Stock

    2019-08-20$68.18/sh5,512$375,8082,281,283 total
Transactions
  • Sale

    Common Stock

    2019-08-19$68.30/sh2,067$141,1762,286,795 total
  • Sale

    Common Stock

    2019-08-20$68.18/sh5,512$375,8082,281,283 total
Brown Robert E. JR
Director10% Owner
Transactions
  • Sale

    Common Stock

    2019-08-19$68.30/sh2,067$141,1762,286,795 total
  • Sale

    Common Stock

    2019-08-20$68.18/sh5,512$375,8082,281,283 total
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $69.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
  • [F2]The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $68.00 to $68.80 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
  • [F3]Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II.
  • [F4]This Form 4 Amendment is being filed for the sole purpose of reporting that sales under the Reporting Person's 10b5-1 diversification plan has completed, and no further sales will take place under the plan.

Issuer

ANI PHARMACEUTICALS INC

CIK 0001023024

Entity typeother

Related Parties

1
  • filerCIK 0001109507

Filing Metadata

Form type
4/A
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 2:13 PM ET
Size
12.9 KB